RankAlpha logo
Back to Rankings

AKBA

Akebia TherapeuticsD
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
Quote time unavailable
View Chart
+
Peers tracked
8
U.S. public peers
Grade Position
Below peers
vs peer average
AKBA vs peer average
44/100
AKBA vs. peer average (D vs. D)
Grade spread
A 1 · C 2 · D 3 · F 2
Graded peers loaded
Coverage
8 graded
100% of tracked

Peer overview

YDES is the first available peer comparator.

Same sector: Pharmaceuticals, Biotechnology & Life Sciences · Cap $238.7M

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerYDESBreeze Acquisition
AKBA
Akebia Therapeutics
YDES
Breeze Acquisition
Grade
D
F
Momentum
16
66
Value
54
46
Sentiment
45
5
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Defensive
Open Side-by-Side ComparisonCompare all

Grade position vs YDES

AKBA / YDES
Grade Position
Below peers
AKBA vs. peer average (D vs. D)
44/100
Momentum
16
YDES
Value
54
AKBA
Sentiment
45
AKBA

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs AKBA
1
YDES
Breeze Holdings Acquisition Corp Common
F
20/100
+1
2
TARA
Protara Therapeutics Inc Common
A
100/100
-3
3
ACB
Aurora Cannabis Inc Common
D
40/100
Even
4
IPHA
Innate Pharma SA ADR
D
40/100
Even
5
RCEL
AVITA Medical Inc Common
C
60/100
-1
YDES is the first peer returned for this comparison set.